Your session is about to expire
← Back to Search
DISC-MA for Depression and Anxiety (PAPI Trial)
PAPI Trial Summary
This trial aims to show how precision treatments can work in adults.
PAPI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PAPI Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current number of participants being enlisted for this clinical trial?
"Indeed, the information on clinicaltrials.gov indicates that this trial is actively seeking participants. The study was initially posted on March 13, 2024, and last revised on the same date. The research team aims to recruit 200 individuals from a singular site."
Are there still opportunities for individuals to participate in this ongoing medical research study?
"As per the details on clinicaltrials.gov, patient recruitment is ongoing for this trial. The initial posting of the study was made on March 13th, 2024, with the most recent update also dated as March 13th, 2024."
Am I eligible to enroll in this clinical trial?
"The trial aims to recruit 200 individuals aged between 18 and 75 experiencing symptoms of depression and anxiety. Notably, potential participants must fulfill the subsequent conditions: Age bracket falls within 18-75 years, Possession or regular use of a smartphone equipped with an up-to-date operating system (Android: OS 8.0+, Apple: iOS 13.0+) along with dependable Wi-Fi access or adequate data plan for interaction with assigned treatment protocol throughout the investigation period, Willingness and availability to actively partake in the program and conclude assessments over a span of four weeks, Proficiency in English reading and writing skills,"
Are individuals who are 18 years of age or older eligible to participate in this research study?
"In this investigation, individuals between the ages of 18 and 75 are sought. Notably, there are a total of 224 trials catering to those younger than 18 years old and 942 focusing on patients above the age of 65."
Share this study with friends
Copy Link
Messenger